Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

A mistake when topping up your appliance and white good with laundry detergent could massively backfire, experts have said.

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

After years of lending and investing in South Florida, Michael Dell’s BDT & MSD Partners is now looking to get into ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

This is the first-to-market cyber-physical trust platform to tackle issues of product safety and counterfeiting, ensuring ...